ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings

Salem, NH, April 06, 2016 --(PR.com)-- ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA on April 5, 2016. While this is the first cytokine assay in the STELLUX® Chemiluminescence product line, the new assay still offers a broad dynamic range similar to other STELLUX® kits. This broad range eliminates the need for users to dilute samples. The highly specific ELISA also includes all standards and controls and can be run in under three hours.

“We are proud to now provide cytokine researchers with the STELLUX® Chemi Human IL-6 ELISA which is a flexible, user friendly and cost-effective tool for measuring IL-6,” explains ALPCO president, Sean Conley. “Additionally, the assay demonstrates excellent correlation to other IL-6 kits available on the market, therefore allowing researchers to use the STELLUX® Chemi Human IL-6 ELISA knowing they will have the ability to correlate to previous IL-6 kits.”

Visit alpco.com or contact Andrea Tarbet at ALPCO to learn more about the STELLUX® Chemi Human IL-6 ELISA.

About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of immunoassay-based products for the North American life science markets. The company has since grown into a premier channel representing over 60 collaborating partners from around the globe. In 2008, ALPCO expanded its capabilities with the launch of an organically developed product line focused in the area of diabetes and obesity research while also remaining true to its roots by continuing to provide “Immunoassays Beyond the Ordinary.”